Results 31 to 40 of about 136,614 (358)

Hepatitis B elimination in children of Slovenian origin born in Slovenia after the introduction of preventive strategies: The results of a national study

open access: yesSlovenian Journal of Public Health, 2022
In Slovenia national strategies to prevent hepatitis B virus (HBV) infection in children were introduced in the mid-nineties. The aim of the present study was to analyze the epidemiological characteristics of chronic hepatitis B infection in children in ...
Kmet Nina Grasselli   +3 more
doaj   +1 more source

HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets [PDF]

open access: yes, 2018
Chronic HBV + HDV infection is associated with greater risk of liver fibrosis, earlier hepatic decompensation, and liver cirrhosis hepatocellular carcinoma compared to HBV mono-infection.
Andreoni, Massimo   +34 more
core   +2 more sources

Hepatitis B Virus (HBV) and S-Escape Mutants: From the Beginning until Now [PDF]

open access: yes, 2015
Despite of the progress made in vaccine and antiviral therapy development, hepatitis B virus (HBV) infection remains a major health care problem. More than 240 million people are chronically infected worldwide showing differences in the severity of liver
Cuestas, María Luján   +4 more
core   +1 more source

Association of mutations in the basal core promoter and pre-core regions of the hepatitis B viral genome and longitudinal changes in HBV level in HBEAG negative individuals: Results from a cohort study in northern Iran [PDF]

open access: yes, 2015
Background: Although certain HBV mutations are known to affect the expression of Hepatitis e antigen, their association with HBV viral level or clinical outcomes is less clear.
Besharat, S.   +7 more
core   +1 more source

HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch Study

open access: yesJournal of Clinical and Translational Hepatology, 2018
Background and Aims: Hepatitis B surface antigen (HBsAg) loss is seldom achieved with nucleos(t)ide analog (NA) therapy in chronic hepatitis B patients but may be enhanced by switching to finite pegylated-interferon (Peg-IFN) alfa-2a.
P. Hu   +26 more
semanticscholar   +1 more source

Seroprevalence of Hepatitis B Virus in HIV Tested Positive Patients Accessing Treatment in Specialist Hospital Jimeta

open access: yesDr. Sulaiman Al Habib Medical Journal, 2021
Background: Human Immunodeficiency Virus (HIV) positive patients are likely to be at risk of other infectious pathogens such as Hepatitis B Virus (HBV).
Mohammed Bashir   +2 more
doaj   +1 more source

New Perspectives on Treatment of Hepatitis B Before and After Liver Transplantation [PDF]

open access: yes, 2016
open5noThe hepatitis B virus (HBV) infects more than 260 million people globally, with increasing incidence, especially in developing countries.
Bortoluzzi, Ilaria   +4 more
core   +1 more source

A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response

open access: yesFrontiers in Immunology, 2019
Development of effective malaria vaccines requires delivery platforms to enhance the immunogenicity and efficacy of the target antigens. This is particularly challenging for transmission-blocking malaria vaccines (TBVs), and specifically for those based ...
A. Marini   +10 more
semanticscholar   +1 more source

HBsAg TAŞIYICILARINDA VE HBsAg(-) KiŞiLERDE HDAg SERO PREVALANSI

open access: yesEuropean Journal of Therapeutics, 1993
Serum samples of 120 HBsAg ( +) asymptomatic carries and 120 sera from blood donors and health care personnel having neither HBsAg nor Anti-HBs were tested for the presence of HDAg. in the first group, 19 of the carries were HDAg positive (% 15.83). In the other group 2 health care personnel were HDAg positive (% 1.66).
İclal Balcı   +2 more
openaire   +1 more source

Evaluation of CLIA plus NAT for detecting HBsAg single-ELISA-reactive samples of blood donors

open access: yesZhongguo shuxue zazhi, 2022
Objective To study the detection performance of HBsAg single-ELISA-reactive samples of blood donors. Methods Two kinds of ELISA reagents from different manufacturers (named as reagents A and B) were used for HBsAg screening.
Jiayi SUN   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy